Search

Filters

Clear Filters
8:25 AM - 8:30 AM PT

1130 - Real-Time AI Compensation in Surface Guided Radiotherapy: A Multicenter Randomized Trial for Submillimeter Setup Accuracy and DIBH Adherence
Speaker: Zhao, Lina, MD, PhD - Department of Radiation Oncology, Xijing Hospital, Air Force Medical University, Xi'an, ShaanXi
8:30 AM - 8:35 AM PT

1131 - Performance of a Novel Frameless and Maskless Robotic Head Motion Compensation System for Stereotactic Radiosurgery in a Realistic Clinical Environment with Human Volunteers
Speaker: Wiersma, Rodney, PhD - University of California Los Angeles, Los Angeles, CA
10:35 AM - 10:40 AM PT

1132 - CT-Guided Online Adaptive Stereotactic Body Radiotherapy for Pancreas Ductal Adenocarcinoma: Early Outcomes and Toxicity Data
Speaker: Lee, Albert, MD - Columbia University Irving Medical Center, New York, NY
10:40 AM - 10:45 AM PT

1133 - First Clinical Results of Carbon Ion Therapy for Pancreatic Cancer in Taiwan: Insights into Efficacy and Side Effects
Speaker: Lai, I-Chun, MD, PhD - Taipei Veterans General Hospital, Taipei, Taipei
10:45 AM - 10:50 AM PT

1134 - A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients with Unresectable and Borderline Resectable Pancreatic Cancer
Speaker: Amit, Uri, MD, PhD, MPH - Tel Aviv Medical Center, Tel Aviv, Tel Aviv
10:50 AM - 10:55 AM PT

1135 - Salvage Adaptive Radiation Therapy for Locoregional Recurrence of Pancreatic Adenocarcinoma
Speaker: Padgett, Michael, MD - Washington University in St. Louis, St. Louis, MO
10:55 AM - 11:00 AM PT

1136 - Stereotactic Body Radiation Therapy vs. Surgical Resection for BCLC Stage 0 Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis
Speaker: Lee, Hye In, MD - Asan Medical Center, University of Ulsan College of Medicine, Seoul, Songpa-gu
11:00 AM - 11:05 AM PT

1137 - Impact of Baseline Liver Function on Survival Outcomes following Initial SBRT vs. SBRT Re-Irradiation for Hepatocellular Carcinoma: An Albumin-Bilirubin Grade Analysis
Speaker: Nakamura, Daisuke, MD, PhD - Nagasaki University Hospital, Nagasaki, Nagasaki
10:35 AM - 10:40 AM PT

1138 - ADAR1 Expression in CD8<sup>+</sup> T Cells Modulates Radiotherapy Response and Prognosis in Non-Small Cell Lung Cancer via Disrupting Mitochondrial Function
Speaker: Tian, Chen, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan, Shandong
10:40 AM - 10:45 AM PT

1139 - Tumor Immune Microenvironment Modulation by Single-Fraction vs. Multifraction SBRT in an Orthotopic NSCLC Mouse Model
Speaker: Bouchard, Lea, MD, MS - University of Sherbrooke, Sherbrooke, QC
2:30 PM - 2:40 PM PT

114 - Phase 3, Randomized, Placebo Controlled Clinical Trial of CAN-2409+Prodrug in Combination with Standard of Care External Beam Radiation (EBRT) for Newly Diagnosed Localized Prostate Cancer
Speaker: Gejerman, Glen, MD, MBA - Hackensack University Medical Center, Hackensack, NJ
10:45 AM - 10:50 AM PT

1140 - hnRNPA1 Impedes the Anti-Tumor Immune Response Effect via Competitively Inhibiting TRIM21-Mediated Ubiquitination and Degradation of CD155
Speaker: Zhang, Lu, MS, none - Chongqing University Cancer Hospital, Shapingba, Chongqing